BrainsWay Announces Promising Results Treating Adults With ADHD With Transcranial Magnetic Stimulation

On February 10, 2020, BrainsWay, LTD announced that its deep transcranial magnetic system (dTMS) was effective as a treatment for adults with attention deficit/hyperactivity disorder (ADHD). Adults who participated in a randomized, controlled, double-blind clinical trial reported statistically significant improvement in their symptoms of inattention. Functional magnetic resonance imaging (fMRI) revealed a significant increase in activity that was observed within the right and left hemispheres of the dorsolateral prefrontal cortex, a part of the brain previously shown to have reduced activity in adults with ADHD. Following the dTMS treatment, the participants reported a 23% to 26% reduction in . . .